New cell therapy aims to reset immune system in devastating autoimmune diseases
NCT ID NCT06947460
Summary
This study is testing a new cell therapy called CD19-BCMA CAR-T for people with severe autoimmune diseases that have not responded to standard treatments. It aims to see if this therapy is safe and can help control diseases like lupus affecting the kidneys, systemic sclerosis, and Sjogren's syndrome with lung complications. The study will enroll about 45 participants to monitor side effects and see if their disease improves.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for REFRACTORY LUPUS NEPHRITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
北京高博医院
RECRUITINGBeijing, China,Beijing, 102200, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.